Confederation of Meningitis Organisations Launches Web Site

GLOUCESTERSHIRE, England, Feb. 22--PRNewswire-AsiaNet/inFoQuest


- COMOonline.org Offers Global Information, Resources -

The Confederation of Meningitis Organisations (COMO), a network of meningitis and children's health organisations throughout the world, today announced the launch of its Web site,

http://www.COMOonline.org.  The site provides information on COMO and its local member groups and support services, as well as resources for those interested in founding their own local organisations to fight against meningitis.

"The Confederation of Meningitis Organisations was founded for the sharing of best practices, information and research across borders," said Philip Kirby, Chief Executive of the Meningitis Trust and President of COMO. "The launch of our Web site will not only strengthen our existing COMO network, but

expand and inspire additional efforts to combat meningitis both locally and globally."

COMOonline.org features a snapshot of the "Establishing a Meningitis Organisation Tool Kit," a product of the COMO member organisations' shared experiences that will help facilitate the establishment of new organisations to help raise the global profile of meningitis. The complete Tool Kit provides case studies illustrating how different local organisations have been developed and poses important questions to consider when establishing a local group. The Web site also consists of: COMO member organisation

profiles; information on upcoming events, activities and programmes; and personal stories from people around the world who have been impacted by meningitis.

Established organisations or individuals who are committed to the elimination of meningitis and/or provide support to those affected by the disease are encouraged to apply for COMO membership through the site and request access to the complete Tool Kit, which is available in English, Spanish, French, Italian,Portuguese, German and Mandarin.

COMO was established at the first World Conference of Meningitis Organisations (WCMO) in

September 2004 and currently is comprised of 14 organisations from 13 countries around the world.  For more information, visit http://www.COMOonline.org.

Initial support for the COMO Web site has been provided by Wyeth Pharmaceuticals.

Note to Editors:

COMO

The Confederation of Meningitis Organisations' mission is to assist member organisations to be sustainable, identifiable and influential sources for information and support services for those people affected by meningitis in their regions and united in their endeavors globally through their membership

of COMO, which is committed to the elimination of meningitis and septicaemia. The founding members include leaders from meningitis and children's health organisations from around the world, including Association Audrey (France), Fundacion Illyria Velasco Carranza (Mexico), GAVI - PneumoADIP (USA), Meningitis Centre (Australia), Meningitis Foundation of America (USA), Meningitis Research Foundation of Canada (Canada), Meningitis Research Foundation (UK and Ireland), Meningitis Trust (Ireland), Meningitis Trust (New
Zealand), Meningitis Trust (UK), Moige (Italy), Philippine Foundation for Vaccination (Philippines), Pneumo-Mening (Brazil) and Pneumo-Mening Centre (Taiwan).

Meningitis and septicaemia

Meningitis can be caused by bacteria (e.g., Haemophilus influenzae type b,Streptococcus pneumoniae and Neisseria meningitidis), as well as viruses. Some bacteria that cause meningitis(inflammation of the lining of the brain) can also cause septicaemia (blood poisoning). Many people who have a meningococcal or a pneumococcal infection have both meningitis and septicaemia, although some have meningitis or septicaemia alone.

The early symptoms of meningitis and septicaemia include fever, vomiting, headache, cold hands and feet, rapid breathing, drowsiness, and stomach, joint or muscle pain. These symptoms may not all appear at once and may be accompanied by other symptoms such as a stiff neck and dislike of bright lights.

Patients suffering from meningococcal septicaemia often develop a non-lanching rash, called a haemorrhagic rash. Septicaemia can develop quickly and in severe cases, the rash may spread as you watch it. It is important to realise that a rash may not always occur, especially with pneumococcal septicaemia.

Both septicaemia and meningitis have high fatality rates.

Bacterial meningitis can be treated with a number of effective antibiotics, although some bacteria are developing resistance to these antibiotics. There also are several effective vaccines available to help protect infants, young children and adults against some causes of meningitis, such as S. pneumoniae, N. meningitidis and Haemophilus influenzae.

For further information please contact:

[email protected] for general questions and those related to membership

SOURCE Confederation of Meningitis Organisations

CONTACT:

Philip Kirby

Meningitis Trust, United Kingdom, President

+44-14-5376-9011

or Bruce Langoulant

Meningitis Centre, Australia, Vice President

+61-08-9489-7791

both of Confederation of Meningitis Organisations

Web site: http://www.COMOonline.org/

--Distributed by AsiaNet (www.asianetnews.net)--


ข่าวMeningitis+o:eventวันนี้

Pfizer joins World Meningitis Day 2010 Prevention of infant Meningitis

? Every year, over a million children, below the age of 5, die or are disabled by pneumonia and meningitis caused by pneumococcal infections[1][2]. ? Streptococcus pneumoniae, also known as pneumococcus, is the number one vaccine-preventable killer of children worldwide. It can cause pneumonia and meningitis. It has also been responsible for the majority of influenza-related deaths during the influenza pandemic outbreaks that occurred in the U.S. in 1918, 1957 and 1968 ? Pediatricians strongly

ภาพข่าว: ระดมสมองเร่งป้องกันโรคเยื่อหุ้มสมองอักเสบ

นางจินตหรา เตชะทักขิญพันธุ์ (แถวนั่ง, ซ้ายสุด) ผู้ช่วยผู้อำนวยการฝ่ายวิชาการ และรักษาการผู้อำนวยการ มูลนิธิสถาบันแสงสว่าง ในฐานะตัวแทนองค์กรจากประเทศไทย ร่วมประชุมประจำปีครั้งที่ 4 ของสมาพันธ์องค์กรโรคเยื่อหุ้มสมองอักเสบ (Confederation of Meningitis...

อย่าผลัดวันประกันพรุ่ง พาบุตรหลานไปรับการฉีดวัคซีนตั้งแต่บัดนี้

สมาพันธ์องค์การโรคเยื่อหุ้มสมองอักเสบ (Confederation of Meningitis Organisations: CoMO) ออกโรงเรียกร้องให้พ่อแม่ผู้ปกครองทั่วเอเชียนำบุตรหลานไปรับวัคซีนป้องกันโรคติดเชื้อนิวโมคอคคัส (pneumococcal disease) เพื่อลดโอกาสที่เด็กจะ...

Don't Delay, Vaccinate Today

The Confederation of Meningitis Organizations (CoMO) today issued a call to action to parents in Asia to immunise their children against pneumococcal disease, to reduce their children's risk of serious illness and preventable death. The call to action comes on the eve of...

สมาพันธ์องค์การโรคเยื่อหุ้มสมองอักเสบเตรียมจัดการประชุมในฮ่องกง นำร่องการประชุมในภูมิภาคเอเชีย แปซิฟิก

สมาพันธ์องค์การโรคเยื่อหุ้มสมองอักเสบ (Confederation of Meningitis Organisations: CoMO) จัดการประชุมประจำปีครั้งที่ 4 ที่โรงแรมไฮแอท รีเจนซี โฮเทล ในชาทิน บนเกาะฮ่องกง ในระหว่างวันที่ 3-5 ตุลาคม พ.ศ...

Meningitis Advocates and Childhood Immunisation Specialists from Around the Globe Come Together in Hong Kong for First Ever Conference in Asia Pacific

The Confederation of Meningitis Organisations (CoMO) is holding its 4th Annual Members Conference at the Hyatt Regency Hotel, Sha Tin, Hong Kong on...

สมาพันธ์องค์การโรคเยื่อหุ้มสมองอักเสบขานรับนโยบายใหม่ของรัฐบาลฮ่องกง

บรูซ แลงกูแลนท์ ประธานสมาพันธ์องค์การโรคเยื่อหุ้มสมองอักเสบ (Confederation of Meningitis Organisations: CoMO) แสดงความชื่นชมการตัดสินใจของรัฐบาลฮ่องกงที่ให้มีการเพิ่มวัคซีนชนิดใหม่เข้าไปในโครงการฉีดวัคซีนสำหรับเด็ก โดยตั้งแต่นี้...

The Confederation of Meningitis Organisations (CoMO) Applauds the Actions of the Government of Hong Kong!

Bruce Langoulant, President of the Confederation of Meningitis Organisations (CoMO), applauds the Government of Hong Kong on the inclusion of a new vaccine to the Childhood Immunisation Program ...

Meningitis Organisations Worldwide Call on Asia Pacific Governments to Protect Children from Deadly Pneumococcal Disease

Data presented this week at the 6th International Symposium for Pneumococci and Pneumococcal Diseases (ISPPD-6) confirms that a universal pneumococcal vaccination programme would...

Hib Vaccine: A Critical Ally in Asia's Effort to Reduce Child Deaths

New Study Shows Hib Vaccine Protects Children From Significant Burden of Life-Threatening Pneumonia and Meningitis - Study Shows Hib Vaccine Could Prevent About 1/3 of Life-Threatening Cases of Bacterial Pneumonia, the Leading...